Prospective, Non-randomized, 36-Month Study of Second-Generation Trabecular Micro-Bypass Stents with Phacoemulsification in Eyes with Various Types of Glaucoma

INTRODUCTION: The aim of this study was to assess 36-month outcomes after cataract surgery and implantation of two second-generation trabecular micro-bypass stents (iStent inject, Glaukos Corporation, San Clemente, CA, USA) into eyes with predominantly primary open-angle glaucoma (POAG) or pseudoexf...

Descripción completa

Detalles Bibliográficos
Autores principales: Hengerer, Fritz H., Auffarth, Gerd U., Riffel, Christoffer, Conrad-Hengerer, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258575/
https://www.ncbi.nlm.nih.gov/pubmed/30430427
http://dx.doi.org/10.1007/s40123-018-0152-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258575/
https://www.ncbi.nlm.nih.gov/pubmed/30430427
http://dx.doi.org/10.1007/s40123-018-0152-8

Ejemplares similares